Detalhe da pesquisa
1.
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial.
Lancet
; 403(10435): 1460-1471, 2024 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554725
2.
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial.
Nat Med
; 29(1): 104-114, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624315
3.
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma.
J Clin Oncol
; 40(17): 1939-1948, 2022 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35254876
4.
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma.
Clin Cancer Res
; 26(22): 5869-5878, 2020 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816891
5.
Measurement properties of the neck disability index: a systematic review.
J Orthop Sports Phys Ther
; 39(5): 400-17, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19521015
6.
G-protein-coupled receptor heterodimerization: assay technologies to clinical significance.
Curr Opin Drug Discov Devel
; 10(5): 580-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17786857